Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03958747 · ClinicalTrials.gov registry record · NA
Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03958747: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT03958747 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03958747, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This pilot clinical trial studies how well ultrasound works in detecting oxaliplatin-induced neuropathy in participants with gastrointestinal cancer. Ultrasound may work better in diagnosing and detecting neuropathy in gastrointestinal cancer participants treated with the chemotherapy drug called oxaliplatin.
Primary Outcome
Tibial nerve cross-sectional area determined by ultrasound in oxaliplatin-induced peripheral neuropathy patients will be transformed to compare to historical data previously collected from healthy adults and oxaliplatin-induced peripheral neuropathy patients using analysis of variance (ANOVA).
Interventions
- OTHER Blood draw
- PROCEDURE Skin Biopsy
- DIAGNOSTIC_TEST Ultrasound - Serial and Tibial Nerve
- OTHER Abbreviated Neurologic Exam
- DIAGNOSTIC_TEST Nerve Conduction Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-12-17 |
| Est. Completion | 2025-11-26 |
| Phase | NA |
What the finished NCT03958747 record still lists
NCT03958747 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Blood draw is the first listed.
NCT03958747 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03958747 about?
NCT03958747 is a clinical study titled "Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy". This pilot clinical trial studies how well ultrasound works in detecting oxaliplatin-induced neuropathy in participants with gastrointestinal cancer. Ultrasound may work better in diagnosing and detecting neuropathy in gastrointestinal cancer participants treated with the chemotherapy drug called ox...
What is the current status of trial NCT03958747?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-12-17. Estimated completion is 2025-11-26.
What interventions are being tested in trial NCT03958747?
The interventions under investigation include: Blood draw (OTHER), Skin Biopsy (PROCEDURE), Ultrasound - Serial and Tibial Nerve (DIAGNOSTIC_TEST), Abbreviated Neurologic Exam (OTHER), Nerve Conduction Study (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03958747?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03958747's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI